Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

See Locations Near You

Summary

The purpose of this study is to assess the efficacy and safety of ZD6474 in patients with NSCLC after Failure of Prior Platinum-based Chemotherapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histologic or cytologic confirmation of NSCLC (locally advanced or metastatic, IB-IV)
Failure of first-line platinum-based chemotherapy

Exclusion Criteria:

Mixed small cell or non-small-cell histology
Bronchoalveolar carcinoma
Prior chemotherapy or herbal preparations must be discontinued more than 4 weeks before the start of study therapy (6 weeks for nitrosoureas, mitomycin and suramin)
Prior treatment with docetaxel

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

129

Study ID:

NCT00047840

Recruitment Status:

Completed

Sponsor:

Genzyme, a Sanofi Company

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Research Site
Los Angeles California, , United States
Research Site
Jacksonville Florida, , United States
Research Site
Atlanta Georgia, , United States
Research Site
New Orleans Louisiana, , United States
Research Site
Boston Massachusetts, , United States
Research Site
Pittsfield Massachusetts, , United States
Research Site
Ann Arbor Michigan, , United States
Research Site
Detroit Michigan, , United States
Research Site
Billings Montana, , United States
Research Site
Great Neck New York, , United States
Research Site
New York New York, , United States
Research Site
Durham North Carolina, , United States
Research Site
Coos Bay Oregon, , United States
Research Site
Philadelphia Pennsylvania, , United States
Research Site
Pittsburgh Pennsylvania, , United States
Research Site
Houston Texas, , United States
Research Site
Brno , , Czech Republic
Research Site
Chomutov , , Czech Republic
Research Site
Hradec , , Czech Republic
Research Site
Ostrava , , Czech Republic
Research Site
Plzen , , Czech Republic
Research Site
Praha , , Czech Republic
Research Site
Budapest , , Hungary
Research Site
Debrecen , , Hungary
Research Site
Deszk , , Hungary
Research Site
Torokbalint , , Hungary

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

129

Study ID:

NCT00047840

Recruitment Status:

Completed

Sponsor:


Genzyme, a Sanofi Company

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
When Should I Consider Clinical Trials?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider